Double hydrophilic block copolymers self-assemblies in biomedical applications.

Degradable copolymers Double-hydrophilic block copolymers Drug delivery systems Polyion complex micelles pH-Responsive polymers

Journal

Advances in colloid and interface science
ISSN: 1873-3727
Titre abrégé: Adv Colloid Interface Sci
Pays: Netherlands
ID NLM: 8706645

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 18 03 2020
revised: 12 07 2020
accepted: 16 07 2020
pubmed: 3 8 2020
medline: 29 6 2021
entrez: 3 8 2020
Statut: ppublish

Résumé

Double-hydrophilic block copolymers (DHBCs), consisting of at least two different water-soluble blocks, are an alternative to the classical amphiphilic block copolymers and have gained increasing attention in the field of biomedical applications. Although the chemical nature of the two blocks can be diverse, most classical DHBCs consist of a bioeliminable non-ionic block to promote solubilization in water, like poly(ethylene glycol), and a second block that is more generally a pH-responsive block capable of interacting with another ionic polymer or substrate. This second block is generally non-degradable and the presence of side chain functional groups raises the question of its fate and toxicity, which is a limitation in the frame of biomedical applications. In this review, following a first part dedicated to recent examples of non-degradable DHBCs, we focus on the DHBCs that combine a biocompatible and bioeliminable non-ionic block with a degradable functional block including polysaccharides, polypeptides, polyesters and other miscellaneous polymers. Their use to design efficient drug delivery systems for various biomedical applications through stimuli-dependent self-assembly is discussed along with the current challenges and future perspectives for this class of copolymers.

Identifiants

pubmed: 32739324
pii: S0001-8686(20)30170-6
doi: 10.1016/j.cis.2020.102213
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Polymers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102213

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest We declare that there is no conflict of interest related to this article.

Auteurs

Ayman El Jundi (A)

IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France; Laboratory of Applied Chemistry (LAC), Faculty of Science III, Lebanese University, P.O. Box 826, Tripoli, Lebanon.

Sytze J Buwalda (SJ)

IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.

Y Bakkour (Y)

Laboratory of Applied Chemistry (LAC), Faculty of Science III, Lebanese University, P.O. Box 826, Tripoli, Lebanon.

Xavier Garric (X)

IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.

Benjamin Nottelet (B)

IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France. Electronic address: benjamin.nottelet@umontpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH